日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Multiple myeloma derived sulfur dioxide drives CAR-T cell exhaustion by inducing mitochondrial dysfunction

多发性骨髓瘤衍生的二氧化硫通过诱导线粒体功能障碍导致CAR-T细胞耗竭。

期刊:Redox Biology
影响因子:11.9
doi:10.1016/j.redox.2026.104040
Yu, Zhengyu; Lin, Hua; He, Jingran; Li, Linfeng; Wang, Zhongwang; Li, Kun; Niu, Ting; Qiu, Bingquan
T细胞
多发性骨髓瘤
T细胞
线粒体
骨髓瘤
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

YMN-V115: a novel humanized BCMA/GPRC5D/CD3 trispecific antibody in relapsed/refractory multiple myeloma

YMN-V115：一种用于治疗复发/难治性多发性骨髓瘤的新型人源化BCMA/GPRC5D/CD3三特异性抗体

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-013986
Li, Jia; Lu, Qizhong; Zhu, Zhixiong; Wang, Xuehui; Chen, Yangji; Zhang, Zongliang; Yu, Zhengyu; Wang, Zeng; Chen, Yongdong; Xie, Hai; Yang, Nian; Lu, Huaqing; Niu, Ting; Nie, Chunlai; Tong, Aiping; Li, Hexian
多发性骨髓瘤
CD3
骨髓瘤
发表日期：2026
文献求助 收藏

CRISPR/Cas9-engineered universal CD123/B7-H3 tandem CAR-T cell for the treatment of acute myeloid leukemia.

利用 CRISPR/Cas9 技术改造的通用 CD123/B7-H3 串联 CAR-T 细胞用于治疗急性髓系白血病。

期刊:Chinese Medical Journal
影响因子:7.3
doi:10.1097/CM9.0000000000003588
Li Hexian, Lu Qizhong, Yu Zhengyu, Wu Zhiguo, Zhu Zhixiong, Li Jia, Zhang Zongliang, Wang Zeng, Yang Nian, Chen Yongdong, Lu Huaqing, Niu Ting, Tong Aiping
白血病
CD123
细胞生物学
T细胞
发表日期：2026
文献求助 收藏

Evidence for the Monitoring of Minimal Residual Disease Dynamics to Guide Clinical Practice in Patients with Multiple Myeloma

监测微小残留病灶动态变化以指导多发性骨髓瘤患者临床实践的证据

期刊:Targeted Oncology
影响因子:4
doi:10.1007/s11523-026-01199-z
Gan, Xinai; Li, Linfeng; Zhang, Li; Zheng, Yuhuan; Niu, Ting; Yu, Zhengyu
多发性骨髓瘤
骨髓瘤
发表日期：2026
文献求助 收藏

Microllm: a structured information extraction tool using large language models and named entity recognition in microbiology

Microllm：一种利用大型语言模型和命名实体识别技术在微生物学领域进行结构化信息提取的工具

期刊:Briefings in Bioinformatics
影响因子:7.7
doi:10.1093/bib/bbaf534
Lu, Jing; Li, Fei; Feng, Lei; Yu, Zhengyu; Lu, Jianyu; Qin, Mingyuan; She, Shengnan; Jiang, Haoqiang; Guo, Zhiming; Xia, Jingjing; Han, Lianyi
微生物学
发表日期：2025
文献求助 收藏

Innovative strategies for improving CAR-T cell therapy: A nanomedicine perspective

改进CAR-T细胞疗法的创新策略：纳米医学视角

期刊:Chinese Medical Journal
影响因子:7.3
doi:10.1097/CM9.0000000000003706
Wang, Mengyao; Yu, Zhengyu; Yuan, Liping; Yang, Peipei; Jing, Caixia; Qu, Ying; Qian, Zhiyong; Niu, Ting
细胞生物学
T细胞
T细胞
免疫/内分泌
发表日期：2025
文献求助 收藏

Anti-FcRL5 CAR-T exhibits anti-MM activity against EMM after progression of anti-BCMA and anti-GPRC5D CAR-T: a case report

抗FcRL5 CAR-T疗法在抗BCMA和抗GPRC5D CAR-T疗法进展后，对EMM表现出抗MM活性：病例报告

期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2024014982
He, Xiaoyuan; Zhang, Xiaomei; Yu, Zhengyu; Meng, Juanxia; Jiang, Yanyu; Zhao, Yifan; Lyu, Hairong; Bai, Xue; Xiao, Xia; Zhao, Mingfeng
多发性骨髓瘤
发表日期：2025
文献求助 收藏

Dietary Flavonoid Intake and Anemia Risk in Children and Adolescents: Insights from National Health and Nutrition Examination Survey

儿童和青少年膳食类黄酮摄入量与贫血风险：来自全国健康和营养调查的启示

期刊:Antioxidants
影响因子:6.6
doi:10.3390/antiox14040395
Li, Linfeng; Wang, Zhongwang; Yu, Zhengyu; Niu, Ting
贫血
代谢
发表日期：2025
文献求助 收藏

Efficacy and safety of chimeric antigen receptor T-cell in the treatment of hematologic malignancy: an umbrella review of systematic review and meta-analysis

嵌合抗原受体T细胞治疗血液系统恶性肿瘤的疗效和安全性：系统评价和荟萃分析的伞状综述

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1608768
Yu, Zhengyu; Jing, Caixia; Xie, Li; Min, Lang; Li, Lingfeng; Wang, Zhongwang; Niu, Ting
肿瘤
T细胞
肿瘤免疫
信号转导
T细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Vascular smooth muscle cell-derived SO(2) sulphenylated interferon regulatory factor 1 to inhibit VSMC senescence.

血管平滑肌细胞衍生的SO(2)磺酰化干扰素调节因子1抑制VSMC衰老

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2025.1516885
Qiu Bingquan, Zhang Shangyue, Ge Shuang, Yu Zhengyu, Wang Deqing, Li Kun, Yu Xiaoqi, Tang Chaoshu, Du Junbao, Jin Hongfang, Huang Yaqian
细胞生物学
发表日期：2025
文献求助 收藏